249 related articles for article (PubMed ID: 15289194)
1. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department.
Sama AE; D'Amore J; Ward MF; Chen G; Wang H
Acad Emerg Med; 2004 Aug; 11(8):867-73. PubMed ID: 15289194
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
Czura CJ; Yang H; Tracey KJ
J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
[TBL] [Abstract][Full Text] [Related]
3. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function.
Tang D; Kang R; Xiao W; Zhang H; Lotze MT; Wang H; Xiao X
Am J Respir Cell Mol Biol; 2009 Dec; 41(6):651-60. PubMed ID: 19265175
[TBL] [Abstract][Full Text] [Related]
4. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.
Sundén-Cullberg J; Norrby-Teglund A; Rouhiainen A; Rauvala H; Herman G; Tracey KJ; Lee ML; Andersson J; Tokics L; Treutiger CJ
Crit Care Med; 2005 Mar; 33(3):564-73. PubMed ID: 15753748
[TBL] [Abstract][Full Text] [Related]
5. Extracellular role of HMGB1 in inflammation and sepsis.
Wang H; Yang H; Tracey KJ
J Intern Med; 2004 Mar; 255(3):320-31. PubMed ID: 14871456
[TBL] [Abstract][Full Text] [Related]
6. Suppressive Effects of Ginsenoside Rh1 on HMGB1-Mediated Septic Responses.
Lee W; Cho SH; Kim JE; Lee C; Lee JH; Baek MC; Song GY; Bae JS
Am J Chin Med; 2019; 47(1):119-133. PubMed ID: 30630344
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen gas reduces HMGB1 release in lung tissues of septic mice in an Nrf2/HO-1-dependent pathway.
Yu Y; Yang Y; Yang M; Wang C; Xie K; Yu Y
Int Immunopharmacol; 2019 Apr; 69():11-18. PubMed ID: 30660872
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes.
Stevens NE; Chapman MJ; Fraser CK; Kuchel TR; Hayball JD; Diener KR
Sci Rep; 2017 Jul; 7(1):5850. PubMed ID: 28724977
[TBL] [Abstract][Full Text] [Related]
9. HMGB1 as a potential therapeutic target.
Wang H; Li W; Goldstein R; Tracey KJ; Sama AE
Novartis Found Symp; 2007; 280():73-85; discussion 85-91, 160-4. PubMed ID: 17380789
[TBL] [Abstract][Full Text] [Related]
10. Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice.
Lee W; Ku SK; Bae JS
Toxicol Appl Pharmacol; 2017 Aug; 329():202-211. PubMed ID: 28610995
[TBL] [Abstract][Full Text] [Related]
11. Endogenous HMGB1 is required in endotoxin tolerance.
Li S; Luo C; Yin C; Peng C; Han R; Zhou J; He Q; Zhou J
J Surg Res; 2013 Nov; 185(1):319-28. PubMed ID: 23866790
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 in sepsis.
Andersson U; Tracey KJ
Scand J Infect Dis; 2003; 35(9):577-84. PubMed ID: 14620138
[TBL] [Abstract][Full Text] [Related]
13. HMGB1, a potent proinflammatory cytokine in sepsis.
Huang W; Tang Y; Li L
Cytokine; 2010 Aug; 51(2):119-26. PubMed ID: 20347329
[TBL] [Abstract][Full Text] [Related]
14. Baicalin inhibits high-mobility group box 1 release and improves survival in experimental sepsis.
Wang H; Liu D
Shock; 2014 Apr; 41(4):324-30. PubMed ID: 24430548
[TBL] [Abstract][Full Text] [Related]
15. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis.
Chen G; Li J; Qiang X; Czura CJ; Ochani M; Ochani K; Ulloa L; Yang H; Tracey KJ; Wang P; Sama AE; Wang H
J Lipid Res; 2005 Apr; 46(4):623-7. PubMed ID: 15687351
[TBL] [Abstract][Full Text] [Related]
16. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y; Lv B; Wang H; Xiao X; Zuo X
Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
[TBL] [Abstract][Full Text] [Related]
17. Targeting high mobility group box 1 as a late-acting mediator of inflammation.
Czura CJ; Tracey KJ
Crit Care Med; 2003 Jan; 31(1 Suppl):S46-50. PubMed ID: 12544976
[TBL] [Abstract][Full Text] [Related]
18. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
Andersson U; Tracey KJ
Rheum Dis Clin North Am; 2004 Aug; 30(3):627-37, xi. PubMed ID: 15261345
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Remifentanil on Expression of High Mobility Group Box 1 in Septic Rats.
Seo KH; Choi JW; Jung HS; Yoo H; Joo JD
J Korean Med Sci; 2017 Mar; 32(3):542-551. PubMed ID: 28145661
[TBL] [Abstract][Full Text] [Related]
20. Dual roles for HMGB1: DNA binding and cytokine.
Czura CJ; Wang H; Tracey KJ
J Endotoxin Res; 2001; 7(4):315-21. PubMed ID: 11717586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
